Proffitt & Goodson’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9
Closed -$100 240
2022
Q4
$100 Hold
9
﹤0.01% 234
2022
Q3
$0 Hold
9
﹤0.01% 266
2022
Q2
$0 Sell
9
-241
-96% -$2.64K ﹤0.01% 278
2022
Q1
$3K Sell
250
-66
-21% -$870 ﹤0.01% 256
2021
Q4
$4K Sell
316
-146
-32% -$1.95K ﹤0.01% 230
2021
Q3
$6K Sell
462
-105
-19% -$1.49K ﹤0.01% 216
2021
Q2
$8K Sell
567
-315
-36% -$4.56K ﹤0.01% 225
2021
Q1
$12K Sell
882
-740
-46% -$12.1K ﹤0.01% 210
2020
Q4
$30K Buy
+1,622
New +$26.5K 0.01% 172

Other funds holding VTRS

Proffitt & Goodson's VTRS Position: Q1 2023 in Review

Proffitt & Goodson sold out of Viatris (VTRS) in Q1 2023, closing a stake of 9 shares — an estimated $100 sold.

Proffitt & Goodson first reported a position in VTRS in Q4 2020 and held it in 9 quarters. The position peaked at $30K in Q4 2020. 988 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

  • Proffitt & Goodson reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
  • Proffitt & Goodson sold 9 Viatris shares in Q1 2023, an estimated $100.
  • Proffitt & Goodson first reported a position in Viatris in Q4 2020 and held it in 9 quarters.
  • Proffitt & Goodson's Viatris position peaked at $30K in Q4 2020.
  • 988 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on Proffitt & Goodson's 13F filing for Q1 2023, filed 26 Apr 2023.